Search

Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite Covid-19 according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S. academic institutions.

… Monday, May 11, 2020 Treatment with chimeric antigen receptor T cell therapy should proceed in patients with B cell non-Hodgkin lymphomas and B cell acute lymphocytic leukemia, despite the challenges of Covid-19, according to the CAR T Cell Consortium, a collaboration of investigators from eight U.S.

Our review summarizes recent developments in treatment planning and delivery, existing clinical evidence, and ongoing prospective trials in major head and neck cancers that may further increase the therapeutic window of proton therapy for patients with head and neck cancer.

… Tuesday, October 13, 2020 Proton beam radiation has distinct tissue-sparing advantages over conventional photon-based radiation, making it especially beneficial for treating localized head and neck cancers, which typically have complex anatomy and are located near vital organs. We recently published

MSK's Neil Iyengar will present at the American Association for Cancer Research special conference about the risk of invasive breast cancer. A new study found that the risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat. These findings suggest that having a normal BMI can provide false reassurance regarding the risk of breast cancer associated with body fat, and they also highlight the potential role of physical activity and exercise even in those who are at a normal weight. For expert interviews, please contact Nicole H. McNamara at [email protected].

… Friday, January 26, 2018 Bottom Line: The risk of invasive breast cancer is increased in postmenopausal women with a normal body mass index (BMI) but higher levels of body fat, meaning that a large portion of the population has an unrecognized risk of developing cancer. In addition, a lower level of

Dr. Sawyers is recognized for his dedication to cancer research, education, collaboration, science policy, advocacy, and funding.

… Friday, April 9, 2021 Memorial Sloan Kettering (MSK) is proud to announce that Charles L. Sawyers, MD, FAACR , Chair of MSK’s Human Oncology and Pathogenesis Program (HOPP) and Howard Hughes Medical Institute Investigator, will receive the 2021 American Association for Cancer Research (AACR) Distinguished

Memorial Sloan Kettering Cancer Center announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient medical facility to be known as The David H. Koch Center for Cancer Care. The new center will provide the most advanced cancer treatments in a dynamic space designed with the needs of patients firmly in mind.

… Wednesday, May 20, 2015 Memorial Sloan Kettering Cancer Center (MSK) today announced that it has received the largest gift in its history, a commitment of $150 million from long-time MSK board member David H. Koch. This unprecedented contribution will transform cancer care with a state-of-the-art outpatient

During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.

… Friday, May 15, 2020 Summary During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments. As leaders in immunotherapy, Memorial Sloan Kettering researchers have spent decades studying how the immune system responds to cancer

Learn how a bone marrow transplant saved the life of a child with a rare blood disease.

… Monday, September 19, 2016 Summary People with blood diseases such as Wiskott-Aldrich syndrome can sometimes be treated successfully with bone marrow transplantation , a technique pioneered by MSK’s Richard O’Reilly . Kim Okochi’s heart sank when nurses told her that her newborn son, Finn, had low platelets

Research is providing new clues about how cancer spreads to spinal fluid, a condition called leptomeningeal metastasis.

… Thursday, March 9, 2017 Summary Leptomeningeal metastasis , when cancer spreads to spinal fluid, is one of the most challenging types of metastatic cancer to treat. Now research is providing clues about how this happens, as well as pointing to possible treatments. Highlights Between 5 and 10 percent

In patients with resected pancreatic ductal adenocarcinoma, alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency genes were associated with favorable prognoses.

… Thursday, July 16, 2020 In patients with resected pancreatic ductal adenocarcinoma (PDAC), alterations in KRAS and TP53 were associated with worse outcomes, whereas alterations in homologous recombination deficiency (HRD) genes were associated with favorable prognoses, according to a study by our research

A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.

… Friday, August 24, 2012 Summary A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs. Cancer experts have long known that virtually all cancers